These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 21925552)

  • 1. Progress in recombinant DNA-derived vaccines for Lassa virus and filoviruses.
    Grant-Klein RJ; Altamura LA; Schmaljohn CS
    Virus Res; 2011 Dec; 162(1-2):148-61. PubMed ID: 21925552
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Progress in filovirus vaccine development: evaluating the potential for clinical use.
    Falzarano D; Geisbert TW; Feldmann H
    Expert Rev Vaccines; 2011 Jan; 10(1):63-77. PubMed ID: 21162622
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vesicular stomatitis virus-based vaccines against Lassa and Ebola viruses.
    Marzi A; Feldmann F; Geisbert TW; Feldmann H; Safronetz D
    Emerg Infect Dis; 2015 Feb; 21(2):305-7. PubMed ID: 25625358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DNA vaccines elicit durable protective immunity against individual or simultaneous infections with Lassa and Ebola viruses in guinea pigs.
    Cashman KA; Wilkinson ER; Wollen SE; Shamblin JD; Zelko JM; Bearss JJ; Zeng X; Broderick KE; Schmaljohn CS
    Hum Vaccin Immunother; 2017 Dec; 13(12):3010-3019. PubMed ID: 29135337
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent immunogenicity and protective efficacy of a multi-pathogen vaccination targeting Ebola, Sudan, Marburg and Lassa viruse.
    Flaxman A; Sebastian S; Appelberg S; Cha KM; Ulaszewska M; Purushotham J; Gilbride C; Sharpe H; Spencer AJ; Bibi S; Wright D; Schmidt I; Dowall S; Easterbrook L; Findlay-Wilson S; Gilbert S; Mirazimi A; Lambe T
    PLoS Pathog; 2024 Jun; 20(6):e1012262. PubMed ID: 38924060
    [TBL] [Abstract][Full Text] [Related]  

  • 6. DNA vaccines for biodefense.
    Dupuy LC; Schmaljohn CS
    Expert Rev Vaccines; 2009 Dec; 8(12):1739-54. PubMed ID: 19943766
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cross-protection conferred by filovirus virus-like particles containing trimeric hybrid glycoprotein.
    Martins K; Carra JH; Cooper CL; Kwilas SA; Robinson CG; Shurtleff AC; Schokman RD; Kuehl KA; Wells JB; Steffens JT; van Tongeren SA; Hooper JW; Bavari S
    Viral Immunol; 2015 Feb; 28(1):62-70. PubMed ID: 25514232
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single shot against Ebola and Marburg virus.
    Baize S
    Nat Med; 2005 Jul; 11(7):720-1. PubMed ID: 16015361
    [No Abstract]   [Full Text] [Related]  

  • 9. Individual and bivalent vaccines based on alphavirus replicons protect guinea pigs against infection with Lassa and Ebola viruses.
    Pushko P; Geisbert J; Parker M; Jahrling P; Smith J
    J Virol; 2001 Dec; 75(23):11677-85. PubMed ID: 11689649
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospects for immunisation against Marburg and Ebola viruses.
    Geisbert TW; Bausch DG; Feldmann H
    Rev Med Virol; 2010 Nov; 20(6):344-57. PubMed ID: 20658513
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
    Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
    J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vaccine research efforts for filoviruses.
    Hart MK
    Int J Parasitol; 2003 May; 33(5-6):583-95. PubMed ID: 12782057
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recombinant Protein Filovirus Vaccines Protect Cynomolgus Macaques From Ebola, Sudan, and Marburg Viruses.
    Lehrer AT; Chuang E; Namekar M; Williams CA; Wong TAS; Lieberman MM; Granados A; Misamore J; Yalley-Ogunro J; Andersen H; Geisbert JB; Agans KN; Cross RW; Geisbert TW
    Front Immunol; 2021; 12():703986. PubMed ID: 34484200
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vaccines against Ebola virus and Marburg virus: recent advances and promising candidates.
    Suschak JJ; Schmaljohn CS
    Hum Vaccin Immunother; 2019; 15(10):2359-2377. PubMed ID: 31589088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Live attenuated recombinant vaccine protects nonhuman primates against Ebola and Marburg viruses.
    Jones SM; Feldmann H; Ströher U; Geisbert JB; Fernando L; Grolla A; Klenk HD; Sullivan NJ; Volchkov VE; Fritz EA; Daddario KM; Hensley LE; Jahrling PB; Geisbert TW
    Nat Med; 2005 Jul; 11(7):786-90. PubMed ID: 15937495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ebola and Marburg virus vaccines.
    Reynolds P; Marzi A
    Virus Genes; 2017 Aug; 53(4):501-515. PubMed ID: 28447193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Ebola and Marburg hemorrhagic fever viruses: update on filoviruses].
    Leroy E; Baize S; Gonzalez JP
    Med Trop (Mars); 2011 Apr; 71(2):111-21. PubMed ID: 21695865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinant vesicular stomatitis virus-based vaccines against Ebola and Marburg virus infections.
    Geisbert TW; Feldmann H
    J Infect Dis; 2011 Nov; 204 Suppl 3(Suppl 3):S1075-81. PubMed ID: 21987744
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Marburg and Ebola--arming ourselves against the deadly filoviruses.
    Peters CJ
    N Engl J Med; 2005 Jun; 352(25):2571-3. PubMed ID: 15972860
    [No Abstract]   [Full Text] [Related]  

  • 20. Vaccine to confer to nonhuman primates complete protection against multistrain Ebola and Marburg virus infections.
    Swenson DL; Wang D; Luo M; Warfield KL; Woraratanadharm J; Holman DH; Dong JY; Pratt WD
    Clin Vaccine Immunol; 2008 Mar; 15(3):460-7. PubMed ID: 18216185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.